Targeting PROX1 transcription factor and its downstream signaling as a novel therapeutic approach for rhabdomyosarcoma

Starting year

2024

Granted funding

Nebeyu Gizaw

6 000 €

---

Funder

Orion Research Foundation sr

Call

Orionin Tutkimussäätiön apurahahaku vuodelle 2024

Other information

Funding decision number

A1171

Fields of science

Biomedicine

Identified topics

cancer